Mobile-Enhanced Prevention Support Study for Men Who Have Sex With Men and Transgender Women Leaving Jail: Protocol for a Randomized Controlled Trial

Gabriel G Edwards, Cathy J Reback, William E Cunningham, Charles L Hilliard, Charles McWells, Sukrit Mukherjee, Robert E Weiss, Nina T Harawa, Gabriel G Edwards, Cathy J Reback, William E Cunningham, Charles L Hilliard, Charles McWells, Sukrit Mukherjee, Robert E Weiss, Nina T Harawa

Abstract

Background: Men who have sex with men (MSM) and transgender women, particularly those who have experienced criminal justice involvement, have particularly high HIV burdens, and a majority of those in jail have substance use disorders (SUDs). MSM and transgender women also experience elevated rates of incarceration. Once community re-entry occurs, individuals are in a critical period for addressing potential risks of HIV and sexually transmitted infection (STI) acquisition and negative sequelae of substance use. Further, the impact experienced by one's social and sexual networks experienced at the time of detention and release have important health implications for MSM and transgender women.

Objective: The purpose of this study is to test a new intervention-Mobile-Enhanced Prevention Support (MEPS)-that involves a GPS-based mobile app called GeoPassport (referred to as GeoPass in practice), incentives, and peer support for promoting HIV prevention, substance use treatment, and use of related services.

Methods: A two-arm, unblinded, randomized controlled trial will seek to enroll 300 HIV-negative MSM and transgender women, aged 18-49 years, with SUDs, who are either in jail or have recently left jail. Participants will be enrolled by study staff and randomized to the MEPS intervention group or usual care group. The intervention group will receive customized wellness goals in addition to GeoPass, cash incentives, and the support of a trained peer mentor for 6 months. Data collection will consist of a baseline survey and three follow-up surveys at 3, 6, and 9 months postenrollment, either in person or by phone or videoconference when necessary. The primary outcomes include establishing a primary care provider; being prescribed and adhering to pre-exposure prophylaxis (PrEP) for HIV; screening for HIV, STIs, and hepatitis C virus; and engagement in recommended treatment for SUDs. Secondary outcomes include obtaining treatment for any identified infections and avoiding recidivism.

Results: Enrollment began in November 2019 and study completion is expected in 2023.

Conclusions: This study will advance our knowledge base on patient navigation and peer mentor interventions. Peer navigation services have been studied for the treatment of HIV, but less often in the context of HIV and STI prevention among sexual and gender minority populations at the time of re-entry into the community from jail. The MEPS study will examine the acceptability and feasibility of combining peer mentor services with a mobile app to facilitate service utilization and participant-peer mentor communication. MEPS will assess patterns of PrEP uptake and utilization in MSM and transgender women leaving jail. The study will provide heretofore unavailable data from persons leaving jail regarding HIV PrEP, STI screening, substance abuse treatment, and service utilization patterns and experiences, including geocoded data for those in the intervention arm.

Trial registration: ClinicalTrials.gov (NCT04036396); https://www.clinicaltrials.gov/ct2/show/NCT04036396.

International registered report identifier (irrid): PRR1-10.2196/18106.

Keywords: HIV; MSM; PrEP; eHealth; hepatitis C; jail; mobile phone; peer navigation; sexually transmitted infections; smartphone; substance use disorder; transgender women.

Conflict of interest statement

Conflicts of Interest: SM is part of the study team and is the lead app developer.

©Gabriel G Edwards, Cathy J Reback, William E Cunningham, Charles L Hilliard, Charles McWells, Sukrit Mukherjee, Robert E Weiss, Nina T Harawa. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 22.09.2020.

Figures

Figure 1
Figure 1
Mobile-Enhanced Prevention Support (MEPS) study flowchart.
Figure 2
Figure 2
Screenshots of the GeoPass app.

References

    1. HIV and Gay and Bisexual Men. Centers for Disease Control and Prevention. 2019. [2020-06-24]. .
    1. James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The Report of the 2015 US Transgender Survey. Washington, DC: National Center for Transgender Equality; 2016. [2020-09-02]. .
    1. STDs in men who have sex with men. Centers for Disease Control and Prevention. 2017. [2020-06-25]. .
    1. Van Gerwen OT, Jani A, Long DM, Austin EL, Musgrove K, Muzny CA. Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: A systematic review. Transgend Health. 2020 Jun 01;5(2):90–103. doi: 10.1089/trgh.2019.0053.
    1. Nuttbrock L, Bockting W, Rosenblum A, Hwahng S, Mason M, Macri M, Becker J. Gender abuse, depressive symptoms, and substance use among transgender women: A 3-year prospective study. Am J Public Health. 2014 Nov;104(11):2199–2206. doi: 10.2105/AJPH.2014.302106.
    1. Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, Elford J, Johnson MA, Gilson R, Fisher M, Wilkins E, Anderson J, McDonnell J, Edwards S, Perry N, O'Connell R, Lascar M, Jones M, Johnson AM, Hart G, Miners A, Geretti A, Burman WJ, Lampe FC. Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: Results from the cross-sectional ASTRA study. Lancet HIV. 2014 Oct;1(1):e22–e31. doi: 10.1016/S2352-3018(14)70001-3.
    1. Meyer IH, Flores AR, Stemple L, Romero AP, Wilson BDM, Herman JL. Incarceration rates and traits of sexual minorities in the United States: National Inmate Survey, 2011-2012. Am J Public Health. 2017 Feb;107(2):267–273. doi: 10.2105/AJPH.2016.303576.
    1. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. Lancet Infect Dis. 2013 Mar;13(3):214–222. doi: 10.1016/S1473-3099(12)70315-8.
    1. Karberg JC, James DJ. Bureau of Justice Statistics. Washington, DC: US Department of Justice; 2005. Jul, [2020-09-02]. Substance dependence, abuse, and treatment of jail inmates, 2002. .
    1. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD. Release from prison--A high risk of death for former inmates. N Engl J Med. 2007 Jan 11;356(2):157–165. doi: 10.1056/NEJMsa064115.
    1. Brinkley-Rubinstein L, Peterson M, Arnold T, Nunn AS, Beckwith CG, Castonguay B, Junious E, Lewis C, Chan PA. Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated. PLoS One. 2018;13(12):e0205593. doi: 10.1371/journal.pone.0205593.
    1. Springer SA, Di Paola A, Azar MM, Barbour R, Krishnan A, Altice FL. Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. Drug Alcohol Depend. 2017 May 01;174:158–170. doi: 10.1016/j.drugalcdep.2017.01.026.
    1. Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community: A potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2012 Mar;33(2):436–444. doi: 10.1016/j.cct.2011.11.002.
    1. Krishnan A, Wickersham JA, Chitsaz E, Springer SA, Jordan AO, Zaller N, Altice FL. Post-release substance abuse outcomes among HIV-infected jail detainees: Results from a multisite study. AIDS Behav. 2013 Oct;17 Suppl 2:S171–S180. doi: 10.1007/s10461-012-0362-3.
    1. Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL, Harawa NT. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: The LINK LA randomized clinical trial. JAMA Intern Med. 2018 Apr 01;178(4):542–553. doi: 10.1001/jamainternmed.2018.0150.
    1. Bradford JB, Coleman S, Cunningham W. HIV system navigation: An emerging model to improve HIV care access. AIDS Patient Care STDS. 2007;21 Suppl 1:S49–S58. doi: 10.1089/apc.2007.9987.
    1. Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors influencing engagement in HIV medical care: Piecing together the fragments of a fractured health care delivery system. Clin Infect Dis. 2011 Jan 15;52 Suppl 2:S238–S246. doi: 10.1093/cid/ciq048.
    1. Robinson R. Masculinity as prison: Sexual identity, race, and incarceration. Calif Law Rev. 2011 Sep 09;99(5):1309–1407.
    1. McCusker J, Bigelow C, Frost R, Garfield F, Hindin R, Vickers-Lahti M, Lewis B. The effects of planned duration of residential drug abuse treatment on recovery and HIV risk behavior. Am J Public Health. 1997 Oct;87(10):1637–1644. doi: 10.2105/ajph.87.10.1637.
    1. Bandura A, Freeman WH, Lightsey R. Self-efficacy: The exercise of control. J Cogn Psychother. 1999 Jan 01;13(2):158–166. doi: 10.1891/0889-8391.13.2.158.
    1. Gifford AL, Sengupta S. Self-management health education for chronic HIV infection. AIDS Care. 1999 Feb;11(1):115–130. doi: 10.1080/09540129948243.
    1. Naar-King S, Bradford J, Coleman S, Green-Jones M, Cabral H, Tobias C. Retention in care of persons newly diagnosed with HIV: Outcomes of the Outreach Initiative. AIDS Patient Care STDS. 2007;21 Suppl 1:S40–S48. doi: 10.1089/apc.2007.9988.
    1. Eaton LA, Matthews DD, Driffin DD, Bukowski L, Wilson PA, Stall RD, POWER Study Team A multi-US city assessment of awareness and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among Black men and transgender women who have sex with men. Prev Sci. 2017 Jul;18(5):505–516. doi: 10.1007/s11121-017-0756-6.
    1. Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among Black and White men and transgender women who have sex with men. AIDS Behav. 2017 May;21(5):1236–1246. doi: 10.1007/s10461-017-1690-0.
    1. Begun AL, Early TJ, Hodge A. Mental health and substance abuse service engagement by men and women during community re-entry following incarceration. Adm Policy Ment Health. 2016 Mar;43(2):207–218. doi: 10.1007/s10488-015-0632-2.
    1. Nelson LE, Wilton L, Moineddin R, Zhang N, Siddiqi A, Sa T, Harawa N, Regan R, Dyer TP, Watson CC, Koblin B, Del Rio C, Buchbinder S, Wheeler DP, Mayer KH, HPTN 061 Study Team Economic, legal, and social hardships associated with HIV risk among Black men who have sex with men in six US cities. J Urban Health. 2016 Feb;93(1):170–188. doi: 10.1007/s11524-015-0020-y.
    1. Nyamathi A, Branson C, Kennedy B, Salem B, Khalilifard F, Marfisee M, Getzoff D, Leake B. Impact of nursing intervention on decreasing substances among homeless youth. Am J Addict. 2012;21(6):558–565. doi: 10.1111/j.1521-0391.2012.00288.x.
    1. Screening recommendations and considerations referenced in the 2015 STD treatment guidelines and original sources. Centers for Disease Control and Prevention. 2016. [2019-10-29]. .
    1. Weiss RE. Modeling Longitudinal Data. New York, NY: Springer Science+Business Media; 2005.
    1. Plummer M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003); 3rd International Workshop on Distributed Statistical Computing (DSC 2003); March 20-22, 2003; Vienna, Austria. 2003.
    1. Harwood JM, Weiss RE, Comulada WS. Beyond the primary endpoint paradigm: A test of intervention effect in HIV behavioral intervention trials with numerous correlated outcomes. Prev Sci. 2017 Jul;18(5):526–533. doi: 10.1007/s11121-017-0788-y.
    1. Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, Holtgrave D. A systematic review of HIV interventions for Black men who have sex with men (MSM) BMC Public Health. 2013 Jul 02;13:625. doi: 10.1186/1471-2458-13-625.
    1. Nyamathi A, Salem BE, Farabee D, Hall E, Zhang S, Faucette M, Bond D, Yadav K. Impact of an intervention for recently released homeless offenders on self-reported re-arrest at 6 and 12 months. J Addict Dis. 2017;36(1):60–71. doi: 10.1080/10550887.2016.1147796.
    1. Nyamathi AM, Marlow E, Branson C, Marfisee M, Nandy K. Hepatitis A/B vaccine completion among homeless adults with history of incarceration. J Forensic Nurs. 2012 Mar;8(1):13–22. doi: 10.1111/j.1939-3938.2011.01123.x.
    1. Zingmond DS, Ettner SL, Cunningham WE. The impact of managed care on access to highly active antiretroviral therapy and on outcomes among Medicaid beneficiaries with AIDS. Med Care Res Rev. 2007 Feb;64(1):66–82. doi: 10.1177/1077558706296243.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera